3,958 results on '"White, Nicholas J"'
Search Results
2. Malaria
3. Preface to the Twenty-fourth Edition
4. Diphtheria
5. CONTRIBUTORS
6. Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
7. The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
8. Severe falciparum malaria in pregnancy in Southeast Asia: a multi-centre retrospective cohort study
9. Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
10. The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
11. Ivermectin metabolites reduce Anopheles survival
12. Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial
13. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
14. Does acute malnutrition in young children increase the risk of treatment failure following artemisinin-based combination therapy? A WWARN individual patient data meta-analysis
15. Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
16. Conservation of Caves and Karst in Australia
17. Northern Territory and Western Queensland
18. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
19. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
20. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
21. Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
22. A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
23. Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar
24. Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
25. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
26. Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
27. Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis
28. Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
29. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
30. Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study
31. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
32. Spatial and temporal distribution of cold-water corals in the Northeast Atlantic Ocean over the last 150 thousand years
33. Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
34. Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
35. Severe malaria
36. Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
37. Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
38. The prognostic and diagnostic value of intraleukocytic malaria pigment in patients with severe falciparum malaria
39. Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
40. Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
41. Environmental DNA as an innovative technique to identify the origins of falsified antimalarial tablets—a pilot study of the pharmabiome
42. A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
43. Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar
44. Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations.
45. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
46. The assessment of antimalarial drug efficacy in vivo
47. Pharmacokinetic considerations in seasonal malaria chemoprevention
48. Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
49. Spend wisely to eliminate malaria
50. Falciparum malaria mortality in sub-Saharan Africa in the pretreatment era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.